ACCESS ONCOLOGY, INC.
ACCESS Oncology, Inc., a privately-held cancer-focused biotechnology company.
ACCESS ONCOLOGY, INC.
Industry:
Biotechnology Health Care
Founded:
1999-01-01
Address:
New York, New York, United States
Country:
United States
Status:
Active
Similar Organizations
Chematics
Chematics is a privately held biotechnology company.
OnCore Biopharma
OnCore Biopharma, Inc. is a privately held biotechnology company.
More informations about "Access Oncology, Inc."
Our Services – Access Oncology
AccessOncology is a business consultancy to the life sciences sector. Our clients include large pharmaceutical organisations, biotech start ups, medical device and diagnostics organisations, …See details»
Access Oncology - PitchBook
Access Oncology was acquired by Keryx Biopharmaceuticals. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate financial data …See details»
About Us - Access Oncology
Sandra has extensive oncology expertise in developing immunotherapies, biologics & targeted agents requiring diagnostics to early and successful in-market launch in ANZ and Asia Pacific, in both R&D & generic markets. ...See details»
Access Oncology, Inc. acquired by Keryx Biopharmaceuticals
Access Oncology, Inc. ACCESS Oncology, Inc., a privately-held cancer-focused biotechnology company. Acquiring Organization: Keryx Biopharmaceuticals Keryx Biopharmaceuticals is a …See details»
Home - Access
ACCESS is integrating the voice of people with lived experience with those of researchers, healthcare providers, industry leaders, and partner organizations who are committed to achieving better health outcomes and quality of life for …See details»
Access Oncology - Overview, News & Similar companies - ZoomInfo
Who is Access Oncology. Access Oncology Inc is a company that operates in the Hospital & Health Care industry. It employs 1-5 people and has $0M-$1M of revenue. The compan y is …See details»
ACCESS Oncology Inc - Company Profile and News
Company profile page for ACCESS Oncology Inc including stock price, company news, executives, board members, and contact informationSee details»
ACCESS Oncology, Inc.:Company Profile & Technical …
ACCESS Oncology is headquartered in United States New York. ACCESS Oncology was founded in 1999. ACCESS Oncology has a total of 4 patents . Related Topics. Oncology …See details»
ACCESS Oncology, Inc.:Acquisition,Acquisition Analysis & Reports ...
Discovery Company profile page for ACCESS Oncology, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Overview, News & Similar companies - ZoomInfo.com
Popular Searches AccessOncology Access Oncology Access Oncology Inc AccessOncology Pty Ltd SIC Code 51,512 NAICS Code 42,424 Show More. AccessOncology Org Chart. Phone …See details»
Access Oncology – Accelerate | Optimise | Consult
Patients with a life-threatening diagnosis want access to the best treatments, as quickly as possible. AccessOncology is a consultancy business focused on accelerating your life …See details»
Oncology market access challenges in Canada | pharmaphorum
May 9, 2025 Innovative cancer drugs reimbursement is a significant issue for Canadian Healthcare professional and their cancer patients. As our market access month comes to a …See details»
Access Oncology, Inc. - Crunchbase
ACCESS Oncology, Inc., a privately-held cancer-focused biotechnology company.See details»
Oncology Market Access Trends & Insights - MORSE Consulting Inc.
Oncology Market Access Trends & Insights Introducing our NEW Oncology Market Access Insights Report MORSE Consulting Inc. is excited to announce the release of our …See details»
Atezolizumab plus bevacizumab and chemotherapy in metastatic ...
1 day ago After the global approval of atezolizumab plus bevacizumab and chemotherapy as first-line metastatic nonsquamous non-small-cell lung cancer (nsqNSCLC) treatment, the …See details»
The Access to Oncology Medicines Coalition: Enhanced in-Country ...
This approach is at the heart of the Access to Oncology Medicines Coalition (ATOM Coalition), a global initiative led by the Union for International Cancer Control (UICC). 17 Since its launch in …See details»
Regulatory Pathways - Access Oncology
We have experience in recently accelerating over 10 Oncology and Haematology molecules to registration 30% faster than historical approval times. Finding the fastest pathway and …See details»
(PDF) Access to Oncology Medicines in Canada: Consensus Forum …
Mar 29, 2024 Patient access to new oncology drugs in Canada is only possible after navigating multiple sequential systemic checkpoints for national regulatory approval, health technology …See details»
ACCESS Oncology, Inc.:Investment,Investment Series,Investment …
Discovery Company profile page for ACCESS Oncology, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Second-Line Endocrine Therapy With or Without Palbociclib …
Apr 28, 2025 The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any …See details»